Against this a recent study has shown that Sirtinol treatment did increase the acetylation level of the Sirt1 target p53 in MCF-7 breast cancer cells, as well as inducing cell death via both apoptotic and autophagic mechanisms [25]. The gene discussed is TP53; the disease is breast carcinoma.